A review of the impact of energy balance on triple-negative breast cancer.


Journal

Journal of the National Cancer Institute. Monographs
ISSN: 1745-6614
Titre abrégé: J Natl Cancer Inst Monogr
Pays: United States
ID NLM: 9011255

Informations de publication

Date de publication:
04 05 2023
Historique:
received: 22 10 2022
revised: 17 02 2023
accepted: 22 02 2023
medline: 5 5 2023
pubmed: 4 5 2023
entrez: 4 5 2023
Statut: ppublish

Résumé

Cancer cells cannot proliferate without sufficient energy to generate biomass for rapid cell division, as well as to fuel their functions at baseline. For this reason, many recent observational and interventional studies have focused on increasing energy expenditure and/or reducing energy intake during and after cancer treatment. The impact of variance in diet composition and in exercise on cancer outcomes has been detailed extensively elsewhere and is not the primary focus of this review. Instead, in this translational, narrative review we examine studies of how energy balance impacts anticancer immune activation and outcomes in triple-negative breast cancer (TNBC). We discuss preclinical, clinical observational, and the few clinical interventional studies on energy balance in TNBC. We advocate for the implementation of clinical studies to examine how optimizing energy balance-through changes in diet and/or exercise-may optimize the response to immunotherapy in people with TNBC. It is our conviction that by taking a holistic approach that includes energy balance as a key factor to be considered during and after treatment, cancer care may be optimized, and the detrimental effects of cancer treatment and recovery on overall health may be minimized.

Identifiants

pubmed: 37139977
pii: 7150916
doi: 10.1093/jncimonographs/lgad011
doi:

Types de publication

Review Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

104-124

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Auteurs

Ngozi D Akingbesote (ND)

Department of Internal Medicine, Yale University, New Haven, CT, USA.
Department of Cellular & Molecular Physiology, Yale University, New Haven, CT, USA.

Dennis Owusu (D)

Department of Internal Medicine, Yale University, New Haven, CT, USA.
Department of Cellular & Molecular Physiology, Yale University, New Haven, CT, USA.
Kwame Nkrumah University of Science and Technology, Kumasi, Ashanti Region, Ghana.

Ryan Liu (R)

Department of Internal Medicine, Yale University, New Haven, CT, USA.
Department of Cellular & Molecular Physiology, Yale University, New Haven, CT, USA.
Cedar Park High School, Cedar Park, TX, USA.

Brenda Cartmel (B)

Yale School of Public Health, New Haven, CT, USA.
Yale Cancer Center, New Haven, CT, USA.

Leah M Ferrucci (LM)

Yale School of Public Health, New Haven, CT, USA.
Yale Cancer Center, New Haven, CT, USA.

Michelle Zupa (M)

Yale School of Public Health, New Haven, CT, USA.

Maryam B Lustberg (MB)

Department of Internal Medicine, Yale University, New Haven, CT, USA.
Yale Cancer Center, New Haven, CT, USA.

Tara Sanft (T)

Department of Internal Medicine, Yale University, New Haven, CT, USA.
Yale Cancer Center, New Haven, CT, USA.

Kim R M Blenman (KRM)

Department of Internal Medicine, Yale University, New Haven, CT, USA.
Yale Cancer Center, New Haven, CT, USA.
Department of Computer Science, Yale University, New Haven, CT, USA.

Melinda L Irwin (ML)

Yale School of Public Health, New Haven, CT, USA.
Yale Cancer Center, New Haven, CT, USA.

Rachel J Perry (RJ)

Department of Internal Medicine, Yale University, New Haven, CT, USA.
Department of Cellular & Molecular Physiology, Yale University, New Haven, CT, USA.
Yale Cancer Center, New Haven, CT, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH